首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >New ruthenium(II) complexes with N-alkylphenothiazines: synthesis, structure, in vivo activity as free radical scavengers and in vitro cytotoxicity.
【24h】

New ruthenium(II) complexes with N-alkylphenothiazines: synthesis, structure, in vivo activity as free radical scavengers and in vitro cytotoxicity.

机译:新的钌(II)与N-烷基吩噻嗪的配合物:合成,结构,作为自由基清除剂的体内活性和体外细胞毒性。

获取原文
获取原文并翻译 | 示例
           

摘要

Three new complexes of the general formula L[RuCl(3)(DMSO)(3)] (1-3), where L = chlorpromazine hydrochloride, trifluoroperazine dihydrochloride or thioridazine hydrochloride, were prepared and characterized by elemental analysis and spectroscopic methods (FT-IR, UV-Vis, (1)H NMR and (13)C NMR). In addition, the crystal structure of the complex 2 containing trifluoroperazine dihydrochloride was solved by single crystal X-ray diffraction. The complex crystallizes in the monoclinic system, space group P2(1), with a = 10.4935(7) A, b = 18.6836(12) A, c = 19.9250(13) A, beta = 98.448(2) degrees, V = 3864.0(4) A(3). The structure was refined to the agreement factors of R = 4.79%, R(w) = 11.23%. The effect of three different doses (0.4, 4.5 and 90.4 microM/kg bw) of complex 2 on superoxide dismutase (SOD) and catalase (CAT) activity was investigated under physiological conditions. Influence on nitrite production (NO(2)(-)) and the level of erythrocytes malondialdehyde (MDA) in rats blood was also evaluated. Complex 2 did not affect the CAT enzyme activity in vivo and did not cause the hydroxyl radicals production. In the 0.4 and 4.5 microM/kg bw doses it showed almost the same or lower SOD activity and nitrite levels, while the dose of 90.4 microM/kg bw significantly increased these parameters. Finally, the cytotoxicity of complexes were assayed in four human carcinoma cell lines MCF-7, MDA-MB-453 (breast carcinoma), SW-480 (colon adenocarcinoma) and IM9 (myeloma multiple cells). Antiproliferative activity in vitro with low IC(50) during 48 h of treatment was observed.
机译:制备了三种新的通式为L [RuCl(3)(DMSO)(3)](1-3)的配合物,其中L =盐酸氯丙嗪,三氟哌嗪二盐酸盐或盐酸硫代哒嗪,并通过元素分析和光谱法(FT -IR,UV-Vis,(1)H NMR和(13)C NMR)。另外,通过单晶X射线衍射解析含有三氟哌嗪二盐酸盐的配合物2的晶体结构。该复合物在单斜晶系空间群P2(1)/ n中结晶,a = 10.4935(7)A,b = 18.6836(12)A,c = 19.9250(13)A,beta = 98.448(2)度, V = 3864.0(4)A(3)。结构被细化为R = 4.79%,R(w)= 11.23%的一致性因子。在生理条件下研究了三种不同剂量(0.4、4.5和90.4 microM / kg bw)的复合物2对超氧化物歧化酶(SOD)和过氧化氢酶(CAT)活性的影响。还评估了对大鼠血液中亚硝酸盐生成(NO(2)(-))和红细胞丙二醛(MDA)水平的影响。复合物2不影响体内CAT酶的活性,也不引起羟基自由基的产生。在0.4和4.5 microM / kg bw剂量下,它显示出几乎相同或更低的SOD活性和亚硝酸盐水平,而90.4 microM / kg bw剂量显着增加了这些参数。最后,在四种人类癌细胞系MCF-7,MDA-MB-453(乳腺癌),SW-480(结肠腺癌)和IM9(多发性骨髓瘤)中测定了复合物的细胞毒性。观察到在48小时的治疗中具有低IC(50)的体外抗增殖活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号